Beacon Trust’s Gilead Sciences GILD Stock Holding History

Beacon Trust’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$2.24M	Sell	31,829 -2,317	-7%	-$163K	0.35%	87
2016 Q4	$2.44M	Sell	34,146 -4,835	-12%	-$359K	0.4%	82
2016 Q3	$3.08M	Buy	38,981 +1,725	+5%	+$140K	0.52%	71
2016 Q2	$3.11M	Buy	37,256 +33,724	+955%	+$2.99M	0.53%	63
2016 Q1	$324K	Buy	3,532 +375	+12%	+$33.8K	0.06%	141
2015 Q4	$319K	Sell	3,157 -8	-0.3%	-$832	0.06%	145
2015 Q3	$311K	Hold	3,165	–	–	0.05%	147
2015 Q2	$371K	Sell	3,165 -75	-2%	-$8.2K	0.06%	146
2015 Q1	$318K	Hold	3,240	–	–	0.05%	168
2014 Q4	$305K	Buy	3,240 +99	+3%	+$10.2K	0.05%	173
2014 Q3	$334K	Buy	3,141 +58	+2%	+$5.68K	0.06%	149
2014 Q2	$256K	Buy	+3,083	New	+$240K	0.04%	165

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Beacon Trust's GILD Position: Q1 2017 in Review

Beacon Trust reduced its Gilead Sciences (GILD) stake by 6.8% in Q1 2017, selling an estimated $163K and leaving 31,829 shares worth $2.24M. The position accounts for 0.35% of the portfolio, ranked #87.

Beacon Trust first reported a position in GILD in Q2 2014 and has held it in 12 quarters since. The position peaked at $3.11M in Q2 2016. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

Beacon Trust held 31,829 shares of Gilead Sciences worth $2.24M as of Q1 2017.
Beacon Trust sold 2,317 Gilead Sciences shares in Q1 2017, an estimated $163K.
Gilead Sciences made up 0.35% of Beacon Trust's portfolio in Q1 2017, its #87 holding.
Beacon Trust first reported a position in Gilead Sciences in Q2 2014 and has held it in 12 quarters since.
Beacon Trust's Gilead Sciences position peaked at $3.11M in Q2 2016.
1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Beacon Trust's 13F filing for Q1 2017, filed 9 May 2017.